Last10K.com

Arcellx, Inc. (ACLX) SEC Filing 8-K Material Event for the period ending Tuesday, February 8, 2022

Arcellx, Inc.

HISTORY TOOLS
CIK: 1786205 Ticker: ACLX

View differences made from one to another to evaluate Arcellx, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Arcellx, Inc..

Continue

Assess how Arcellx, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Arcellx, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

Tools

Material Contracts, Statements, Certifications & more

Arcellx, Inc. provided additional information to their SEC Filing as exhibits

Exhibit 3.1: Articles Of Incorporation
Exhibit 3.2: Articles Of Incorporation
Exhibit 99.1: Additional Exhibits
Ticker: ACLX
CIK: 1786205
Form Type: 8-K Corporate News
Accession Number: 0001193125-22-032077
Submitted to the SEC: Wed Feb 09 2022 10:25:00 AM EST
Accepted by the SEC: Wed Feb 09 2022
Period: Tuesday, February 8, 2022
Industry: Biological Products No Disgnostic Substances
Events:
  1. Bylaw Change
  2. Financial Exhibit
  3. Regulated Disclosure

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/aclx/0001193125-22-032077.htm